Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Bergamo
Clinical trial register · Italy

Clinical Trials in Bergamo, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 81 Rome 73 Naples 48 Genoa 28 Bologna 21
Narrow the registerReset
Recruitment status
Phase
Site location
Milan81 Rome73 Naples48 Genoa28 Bologna21
All 81 locations
Target enrolment
to

Trials with a site in Bergamo

16 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Naples, Meldola, Parma, Aviano, Rome, Bergamo, Brescia, Milan
2026-05-21
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Bergamo, Catanzaro, Bologna, Rome, Milan, Palermo, Perugia
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Bergamo, Bari, Catanzaro, Bologna, Rome, San Donato Milanese (MI), Palermo, Pisa
2026-03-16
Recruiting
Hoffmann-La Roche
Observational
700
Lecce, Naples, Modena, Ravenna, Rome, Genoa, Bergamo, Milan
2025-07-15
Recruiting
Hoffmann-La Roche
Phase 3
182
Bologna, Bergamo, Milan, Alessandria, Turin
2023-10-22
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Naples, Bologna, Modena, Genoa, Bergamo, Milan, Rozzano, Catania
2023-09-18
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
Hoffmann-La Roche
Observational
6,000
Chieti, Bari, Catanzaro, Naples, Udine, Rome, Genoa, Bergamo
2022-11-21
Active, closed
Hoffmann-La Roche
Phase 1/2
90
Bologna, Bergamo, Milan, Turin
2022-10-17
Active, closed
Hoffmann-La Roche
Phase 3
746
Foggia, Naples, Parma, Rome, Bergamo, Milan, Mondovì (CN), Catania
2021-03-17
Active, closed
Hoffmann-La Roche
Phase 1/2
210
Parma, Bergamo, Magnago
2020-09-03
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
Naples, Meldola, Aviano, Rome, Bergamo, Cremona, Milan, Monza
2017-09-22
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 October 2026. https://priyalifescience.com/clinical-trials-italy/city/bergamo

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies with a site in Bergamo that also match the filters currently applied.

How many clinical trials are recruiting in Bergamo?

8 of the 16 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bergamo), 16 studies
PhaseStudiesRecruitingShare
Phase 37543.8%
Phase 1/24025%
Observational2112.5%
Phase 2/32112.5%
Phase 2116.3%

Most active sponsors

Lead sponsors with the most studies (Bergamo)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche168
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.